Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug.
21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug., “Determination of reasons for voluntary withdrawal of a listed drug”, is a CFR section of 21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications; in force.
https://ontology.bommaritollc.com/id/01a0f094-c4db-75c6-a455-cdd5d2dc36cc
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 21 CFR 314.161 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Determination of reasons for voluntary withdrawal of a listed drugen |
| schema:url | |
| skos:prefLabel | 21 CFR 314.161 Determination of reasons for voluntary withdrawal of a listed drug.en |
Related
Cited by (5)eli:cites
- 21 CFR 314.122 Submitting an abbreviated application for, or a 505(j)(2)(C) petition that relies on, a listed drug that is no longer marketed.
- 21 CFR 314.127 Refusal to approve an ANDA.
- 21 CFR 314.162 Removal of a drug product from the list.
- 21 CFR 314.93 Petition to request a change from a listed drug.
- 21 U.S.C. 355 New drugs